Wire · opportunities
Cervical disc device outperforms fusion in FDA trial
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 July 2026 · Fusion42 review
Synergy Spine's Synergy Disc, a motion-preserving cervical disc replacement device, reached 100 implants in 100 days following FDA approval and demonstrated clinical superiority to fusion in its IDE trial with an 87.1% success rate at 24 months.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
If you supply materials, tooling or manufacturing for cervical implants, Synergy just proved the market will abandon fusion for motion-preserving devices—and Medtronic, Stryker and Zimmer now have a validated competitive threat to protect market share. Call your spine surgeon customers this week to understand which procedures they're converting.
◆ Coverage
1 source · 21 Jul 2026
◆ Related on Wire
◆ Topics